SavedAdd your journal

Journals / Ankara Medical Journal / 2016 / Cilt: 16 - Sayı: 4

The Association of Leukocyte Increase with Hyperandrogenism and Body Mass Index in Women with Polycystic Ovary Syndrome

Polikistik Over Sendromu Olan Kadınlarda Artan Lökosit Sayısının Hyperandrojenizm ve Vücut Kitle İndeksi ile İlişkisi

Şevin DEMİR
Şule TEMİZKAN
Pages
339–346
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Inflammatory markers, WBC [6.00 (4.51‐7.17) vs. 7.20 (5.91‐8.41);(P

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of this study was to compare the white blood cells (WBC) count in patients withpolycystic ovary syndrome (PCOS) with the controls and to assess its relationship between metabolicmarkers and hormonal measures.
📊
Key Findings & Data:One hundred‐thirty women withPCOS and 71 healthy women with regular menses were included in the study.
💡
Conclusion & Impact:Inflammatory markers, WBC [6.00 (4.51‐7.17) vs. 7.20 (5.91‐8.41);(P
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: The aim of this study was to compare the white blood cells (WBC) count in patients withpolycystic ovary syndrome (PCOS) with the controls and to assess its relationship between metabolicmarkers and hormonal measures. Materials and Methods: The study was conducted retrospectively. One hundred‐thirty women withPCOS and 71 healthy women with regular menses were included in the study. General characteristics andanthropometric measures were analyzed. Hormonal, metabolic and inflammatory parameters werestudied in all subjects at the follicular phase of the menstrual cycle. Results:The average age and body mass index (BMI) of PCOS and the control groups were similar(P=0.071 and P=0.063, respectively). Inflammatory markers, WBC [6.00 (4.51‐7.17) vs. 7.20 (5.91‐8.41);(P

Özet

Amaç: Bu çalışmanın amacı, polikistik over sendromlu (PKOS) hastalarla kontrol grubunun lökosit (WBC) sayılarını karşılaştırmak ve lökosit sayısı ile metabolik belirteçler ve hormonal değerler arasındaki ilişkiyi değerlendirmektir. Materyal ve Metot: Çalışma retrospektif olarak yapıldı. Yüz otuz polikistik over sendromlu ve düzenli adet gören 71 sağlıklı kadın çalışmaya alındı. Genel özellikleri ve antropometrik ölçümleri analiz edildi. Tüm katılımcıların hormonal, metabolik ve inflamatuar parametreleri adet döngüsünün foliküler fazında çalışıldı. Bulgular: PCOS ve kontrol grubunun yaş ortalaması ve vücut kitle indeksi (VKİ) benzerdi (sırasıyla, P = 0.071 ve P = 0.063). Inflamatuar belirteçler, WBC [6.00 (4.51‐7.17) karşı 7.20 (5.91‐8.41); (P

🔖

Cite This Article

DEMİR, Ş., TEMİZKAN, Ş. (2022). The Association of Leukocyte Increase with Hyperandrogenism and Body Mass Index in Women with Polycystic Ovary Syndrome. Ankara Medical Journal, Cilt: 16 - Sayı: 4, 339–346. https://ajindex.com/articles/442064

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Azziz R, Adashi EY. Stein and Leventhal: 80 years on. Am J Obstet Gynecol 2016
  2. 214(2):247. Rotterdam ESHRE/ASRM‐Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long‐term health risks related to polycystic ovary syndrome. Fertil Steril 2004
  3. 81(1):19‐25. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004
  4. 89(6):2745‐9. Bassuk SS, Rifai N, Ridker PM. High‐sensitivity C‐reactive protein: clinical importance. Curr Probl Cardiol 2004
  5. 29(8):439‐93. Tardif JC, Heinonen T, Orloff D, Libby P. Vascular biomarkers and surrogates in cardiovascular disease. Circulation 2006
  6. 113(25):2936‐42. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005
  7. 111(25):3481‐8. Kannel WB, Anderson K, Wilson PW. White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA 1992
  8. 267(9):1253‐6. Corbould A. Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women. J Endocrinol 2007
  9. 192(3):585‐94. Bhasin S. Regulation of body composition by androgens. J Endocrinol Invest 2003
  10. 26(9):814‐22. Spritzer PM, Lecke SB, Satler F, Morsch DM. Adipose tissue dysfunction, adipokines, and low‐ grade chronic inflammation in polycystic ovary syndrome. Reproduction 2015
  11. 149(5):R219‐27. Phelan N, O'Connor A, Kyaw Tun T, et al. Leucocytosis in women with polycystic ovary syndrome (PCOS) is incompletely explained by obesity and insulin resistance. Clin Endocrinol (Oxf ) 2013
  12. 78(1):107‐13. Keskin Kurt R, Okyay AG, Hakverdi AU, et al. The effect of obesity on inflammatory markers in patients with PCOS: a BMI‐matched case‐control study. Arch Gynecol Obstet 2014
  13. 290(2):315‐9. Herlihy AC, Kelly RE, Hogan JL, O'Connor N, Farah N, Turner MJ. Polycystic ovary syndrome and the peripheral blood white cell count. J Obstet Gynaecol 2011
  14. 31(3):242‐4. Xiong YL, Liang XY, Yang X, Li Y, Wei LN. Low‐grade chronic inflammation in the peripheral blood and ovaries of women with polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol 2011
  15. 159(1):148‐50. Shi Y, Han T, Cui L, et al. White blood cell differential counts in patients with polycystic ovary syndrome: a pilot study on Chinese women. Eur J Obstet Gynecol Reprod Biol 2013
  16. 170(1):162‐4. Papalou O, Livadas S, Karachalios A, et al. White blood cells levels and PCOS: direct and indirect relationship w